Codiak Biosciencesinc Stock Fundamentals

CDAKDelisted Stock  USD 0.01  0  14.15%   
Codiak BioSciencesInc fundamentals help investors to digest information that contributes to Codiak BioSciencesInc's financial success or failures. It also enables traders to predict the movement of Codiak Stock. The fundamental analysis module provides a way to measure Codiak BioSciencesInc's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Codiak BioSciencesInc stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Codiak Current Valuation Analysis

Codiak BioSciencesInc's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Enterprise Value

 = 

Market Cap + Debt

-

Cash

More About Current Valuation | All Equity Analysis

Current Codiak BioSciencesInc Current Valuation

    
  30.86 M  
Most of Codiak BioSciencesInc's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Codiak BioSciencesInc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition

In accordance with the recently published financial statements, Codiak BioSciencesInc has a Current Valuation of 30.86 M. This is 99.79% lower than that of the Biotechnology sector and 99.34% lower than that of the Health Care industry. The current valuation for all United States stocks is 99.81% higher than that of the company.

Codiak BioSciencesInc Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Codiak BioSciencesInc's current stock value. Our valuation model uses many indicators to compare Codiak BioSciencesInc value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Codiak BioSciencesInc competition to find correlations between indicators driving Codiak BioSciencesInc's intrinsic value. More Info.
Codiak BioSciencesInc is number one stock in earnings per share category among related companies. It is the top company in revenue category among related companies . . Comparative valuation analysis is a catch-all model that can be used if you cannot value Codiak BioSciencesInc by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Codiak BioSciencesInc's Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Codiak BioSciencesInc's earnings, one of the primary drivers of an investment's value.

Codiak Total Asset Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Codiak BioSciencesInc's direct or indirect competition against its Total Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Codiak BioSciencesInc could also be used in its relative valuation, which is a method of valuing Codiak BioSciencesInc by comparing valuation metrics of similar companies.
Codiak BioSciencesInc is currently under evaluation in total asset category among related companies.

Codiak Fundamentals

About Codiak BioSciencesInc Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Codiak BioSciencesInc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Codiak BioSciencesInc using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Codiak BioSciencesInc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Codiak BioSciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing exosome-based therapeutics for the treatment of oncology, neuro-oncology, neurology, neuromuscular diseases, infectious diseases, and other diseases. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts. Codiak Biosciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 102 people.

Pair Trading with Codiak BioSciencesInc

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Codiak BioSciencesInc position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Codiak BioSciencesInc will appreciate offsetting losses from the drop in the long position's value.

Moving together with Codiak Stock

  0.86PTAIY Astra International TbkPairCorr
  0.7PKX POSCO Holdings Financial Report 25th of April 2024 PairCorr

Moving against Codiak Stock

  0.94TRV The Travelers Companies Fiscal Quarter End 31st of March 2024 PairCorr
  0.85MRK Merck Company Fiscal Quarter End 31st of March 2024 PairCorr
  0.78WMT Walmart Financial Report 16th of May 2024 PairCorr
  0.77DIS Walt Disney Aggressive PushPairCorr
  0.71CAT Caterpillar Fiscal Quarter End 31st of March 2024 PairCorr
The ability to find closely correlated positions to Codiak BioSciencesInc could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Codiak BioSciencesInc when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Codiak BioSciencesInc - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Codiak BioSciencesInc to buy it.
The correlation of Codiak BioSciencesInc is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Codiak BioSciencesInc moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Codiak BioSciencesInc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Codiak BioSciencesInc can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation.
Note that the Codiak BioSciencesInc information on this page should be used as a complementary analysis to other Codiak BioSciencesInc's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

Other Consideration for investing in Codiak Stock

If you are still planning to invest in Codiak BioSciencesInc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Codiak BioSciencesInc's history and understand the potential risks before investing.
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.